Full Text
EE205 Impact of Polatuzumab Vedotin as First-Line Therapy for DLBCL on Subsequent Treatments: Brazilian Model

Abstract

Authors

Samir Nabhan Douglas Castro Veronica E. Mata

Back to Volume 28, Supplemental Issue 6S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×